New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...

Ozempic (semaglutide) and Mounjaro (tirzepatide ... doctor to see if these warnings apply to you. Boxed warning: Risk of thyroid cancer Ozempic and Mounjaro both have a boxed warning for the ...

Semaglutide also delays gastric emptying ... but the label indicates thyroid cancer risk. Contraindications include a personal or family history of medullary thyroid carcinoma (MTC) or multiple ...

Ozempic (semaglutide) is a prescription drug that ... Based on animal studies, it’s thought that Ozempic may increase your risk of thyroid cancer. It’s important to note that animal studies ...

Building on results of the landmark SELECT trial, SCORE shows cardiovascular (CV) risk ... semaglutide injection 2.4 mg contains a Boxed Warning for possible thyroid tumors, including cancer ...

Ozempic (semaglutide) is a brand-name drug ... Ozempic has a boxed warning for risk of thyroid cancer, and metformin has a boxed warning for risk of lactic acidosis. A boxed warning is a serious ...

A new analysis of FDA adverse event reports suggests a potential link between tirzepatide and thyroid cancer. Learn what this ...

Dr. Michael Greger is famous for several books including “How Not to Die,” and for his website nutritionfacts.org. He ...

Researchers suggest the 20% reduction in nonfatal heart attacks was the primary driver of this benefit for patients with type ...

Building on results of the landmark SELECT trial, SCORE shows cardiovascular (CV) risk reduction with use of semaglutide 2.4 mg in a real-world environment 1 SCORE is a retrospective ...